ABSI
Absci Corp
$10.60
-0.87 (-7.59%)
At close · Jul 10
Market Cap
$1.65B
Shares
155,905,056
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.8M
-38.2%
FY2025
Net Income
-$115.18M
-11.7%
FY2025
Operating Margin
-4297.04%
-1895.4pp
FY2025
Diluted EPS
-$0.84
+10.6%
FY2025
Operating Cash Flow
-$92.93M
-28.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $1.84M | $2.8M | $4.53M | $5.72M | $5.75M | $4.78M | $4.78M | |
| $84.33M | $81.42M | $63.86M | $48.07M | $58.91M | $44.59M | $11.45M | |
| $34.64M | $35.06M | $36.17M | $37.83M | $40.55M | $28.78M | $5.5M | |
| — | $3.4M | $3.4M | $3.4M | $3.4M | $2.1M | — | |
| $11.4M | $11.74M | $13.39M | $14M | $13.04M | $6.65M | $1.13M | |
| $125.27M | $123.12M | $113.42M | $121.23M | $112.5M | $80.02M | $18.08M | |
| -$123.43M | -$120.32M | -$108.89M | -$115.52M | -$106.75M | -$75.24M | -$13.3M | |
| — | -4297.04% | -2401.59% | -2020.2% | -1857.49% | -1573.36% | -278.26% | |
| -$112.04M | -$108.58M | -$95.5M | -$101.52M | -$93.71M | -$68.58M | -$12.17M | |
| $148K | $209K | $565K | $1.01M | $972K | $3.43M | $634K | |
| $5.09M | $5.2M | $5.85M | $5.05M | $1.39M | -$34.62M | -$1.05M | |
| -$118.35M | -$115.11M | -$103.04M | -$110.47M | -$105.37M | -$109.86M | -$14.35M | |
| $91K | $69K | $70K | $100K | -$461K | -$8.9M | $0 | |
| -$118.44M | -$115.18M | -$103.11M | -$110.57M | -$104.9M | -$100.96M | -$14.35M | |
| — | -4113.68% | -2274.06% | -1933.65% | -1825.37% | -2111.25% | -300.27% | |
| -$97.67M | — | — | -$110.57M | -$104.9M | -$103.24M | -$49.47M | |
| -$118.15M | -$114.59M | -$103.07M | -$110.48M | -$105.01M | -$100.97M | -$14.35M | |
| USD/shares | — | -$0.84 | -$0.94 | -$1.20 | -$1.15 | -$2.08 | -$3.19 |
| USD/shares | — | -$0.84 | -$0.94 | -$1.20 | -$1.15 | -$2.08 | -$3.19 |
| shares | — | 136.78M | 110.24M | 92.03M | 90.85M | 49.69M | 15.49M |
| shares | — | 136.78M | 110.24M | 92.03M | 90.85M | 49.69M | 15.49M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.05×
EV/EBIT
—
Biotechnology median 25.73×
P/E (TTM)
—
Biotechnology median 7.52×